A Tech Review blog post discusses the work of Richard Lifton, who studies human outliers, so-called "extreme phenotypes" -- including a man with extremely high bone density. Lifton found a link to bone density with a mutation in the LDL-related receptor protein 5 gene and, now, a drug targeting part of that molecular pathway is in clinical testing to treat osteoporosis.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Oxford Nanopore Technologies is looking into dual listings in London and Hong Kong, according to the South China Morning Post.

The New York Times looks into medical research funding in the US and how the grant system might not be funding the best work.

US lawmakers proposed increasing the National Science Foundation budget, including its facilities account, Science reports.

In PNAS this week: effects of gene deletions on bacterial metabolic networks, genetic responses to sea star wasting disease, and more.